Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Filtros aplicados

Base de dados
Intervalo de ano de publicação
1.
West Indian med. j ; 42(3): 121-3, Sept. 1993.
Artigo em Inglês | MedCarib | ID: med-9233

RESUMO

A randomized controlled trial of Solcoseryl, DuoDerm and conventional conservative therapy with Eusol has been performed in 32 patients with homozygous sickle-cell (SS) disease. After 12 weeks' baseline observation, patients were randomized to one of three therapies and monitored for a further 12 weeks. Of 44 ulcerated legs, 20 received control treatment, 12 Solcoseryl and 12 DuoDerm. DuoDerm was generally unacceptable, and two-thirds of the patients defaulted from this treatment. Solcoseryl increased ulcer healing compared to the controls but the difference was not significant. Solcoseryl was well tolerated and may have a role in the treatment of chronic leg ulcers of sickle-cell disease. (AU)


Assuntos
Humanos , Masculino , Feminino , Anemia Falciforme/complicações , Úlcera da Perna/tratamento farmacológico , Actiemil/uso terapêutico , Coloides/uso terapêutico , Curativos Oclusivos , Cooperação do Paciente , Ensaios Clínicos Controlados Aleatórios como Assunto , Jamaica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA